Efficacy of Addition of Antiangiogenic Agents to Taxanes-Containing Chemotherapy in Advanced Nonsmall-Cell Lung Cancer: A Meta-Analysis and Systemic Review

Preclinical researches indicated a potential synergistic effect of taxanes-containing chemotherapy (TCC) and antiangiogenic agents (AAs) on the treatment of advanced nonsmall-cell lung cancer (NSCLC). The advantage of adding AA to TCC in the real world remains confusing. We summarized the current ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheng, Jin, Yang, Yun-Peng, Yang, Bi-Jun, Zhao, Yuan-Yuan, Ma, Yu-Xiang, Hong, Shao-Dong, Zhang, Ya-Xiong, Zhao, Hong-Yun, Huang, Yan, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616571/
https://www.ncbi.nlm.nih.gov/pubmed/26252298
http://dx.doi.org/10.1097/MD.0000000000001282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616571/
https://www.ncbi.nlm.nih.gov/pubmed/26252298
http://dx.doi.org/10.1097/MD.0000000000001282

Ejemplares similares